TITLE

HIV co-infection with hepatitis B and C viruses among Nigerian children in an antiretroviral treatment programme

AUTHOR(S)
Sadoh, A. E.; Sadoh, W. E.; Idaoriyekemwen, N. J.
PUB. DATE
March 2011
SOURCE
South African Journal of Child Health;Mar2011, Vol. 5 Issue 1, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Nigeria has one of the world's largest burdens of children living with HIV and is highly endemic for hepatitis B. This study set out to determine the prevalence of hepatitis B and C infections among HIV-infected children and to identify the factors associated with these co-infections. Method. We studied 155 HIV-infected children. Information on socio-demographics and history of exposure to risk factors such as scarification, blood transfusion, unsafe injections and circumcision were obtained. All the children were tested for the presence of hepatitis B surface antigen and antibodies to hepatitis C. Result. The prevalence of HIV/HBV co-infection was 7.7%, while that of HIV/HCV co-infection was 5.2%. No child was co-infected with all three viruses. Children who were co-infected with HCV were more likely to be older than 5 years. There was no significant association between co-infection with either of the hepatitis viruses and socio-economic status, gender, number of persons living in the household, World Health Organization clinical stage, route of acquisition of HIV, scarification, blood transfusion, unsafe injection or circumcision. Conclusion. The rate of HIV co-infection with hepatitis B and C in children is significant. HIV-infected children should be screened for these viruses. Those found to be negative and not immunised for hepatitis B should be immunised. Since the natural history of these co- infections in children is not known, it is imperative that affected patients be followed up adequately.
ACCESSION #
62095090

 

Related Articles

  • VIRUS DE LA HEPATITIS B E INFECCIÓN POR VIH/SIDA EN NIÑOS. SÁNCHEZ-PÉREZ, MAIRA PATRICIA // Revista Gastrohnup;2012, Vol. 14 Issue 2, p66 

    HIV/AIDS in children has increased worldwide and in our environment is no exception, although for many years has changed the natural history of disease using highly effective antiretroviral therapy (HAART). The most frequent way of transmission of Hepatitis B Virus (HBV) is contact with blood or...

  • Outcome of Intravenous Immunoglobulin-Transmitted HTLV-I, Hepatitis B, Hepatitis C, and HIV infections. Foroughipour, Mohsen; Jabbari Azad, Farahzad; Farid hosseini, Reza; Shirdel, Abbas; Reza Khalighi, Amir; Yousefzadeh, Hadis; Sadri, Homa; Moghiman, Toktam; Hekmatkhah, Hossein // Iranian Journal of Basic Medical Sciences;Mar2013, Vol. 16 Issue 3, p228 

    Objective(s): Since each unit of Intravenous Immunoglobulin (IVIG) is obtained from different blood donors, blood-borne viral diseases is of high importance. We aimed at investigating the prevalence of various viral infections: Human T-cell Lymphotropic Virus Type 1 (HTLV-I), Hepatitis B (HBV),...

  • Hepatitis B, hepatitis C and HIV co-infection at an antiretroviral centre in Delhi. Raizada, A.; Dwivedi, S.; Bhattacharya, S. // Tropical Doctor;Jul2011, Vol. 41 Issue 3, p154 

    With an estimated 5.7 million people living with HIV/AIDS, India has the highest HIV/AIDS prevalence in the world, according to UNAIDS. Due to similar routes of transmission, co-infection of HIV with hepatitis B and hepatitis C viruses is a common event with significant clinical implications....

  • Co-infectionwith hepatitis viruses among HIV-infected individuals at a tertiary care centre in South India. Kosaraju, Kranthi; Padukone, Shashiraja; Bairy, Indira // Tropical Doctor;Jul2011, Vol. 41 Issue 3, p170 

    We studied the occurrence of hepatitis B (HBV) and hepatitis C (HCV) virus co-infections in human immunodeficiency virus (HIV)-infected individuals in a tertiary care centre. The occurrence of co-infections in our study was less than in the literature reported from the West. However, routine...

  • Occult Hepatitis B Virus infection in ART-Naive HIV-Infected Patients seen at a Tertiary Care Centre in North India. Gupta, Swati; Singh, Sarman // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p53 

    Background: Co-infections of hepatitis B and C viruses are frequent with HIV due to shared routes of transmission. In most of the tertiary care health settings, HIV reactive patients are routinely tested for HBsAg and anti-HCV antibodies to rule out these co-infections. However, using the...

  • Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. Tessema, Belay; Yismaw, Gizachew; Kassu, Afework; Amsalu, Anteneh; Mulu, Andargachew; Emmrich, Frank; Sack, Ulrich // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p111 

    Background: Transfusion-transmissible infectious agents such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis are among the greatest threats to blood safety for the recipient. This study aimed to determine the seroprevalence, risk factors and...

  • DRUG PARAPHERNALIA LAWS AND INJECTION-RELATED INFECTIOUS DISEASE RISK AMONG DRUG INJECTORS. Bluthenthal, Ricky N.; Kral, Alex H.; Erringer, Elizabeth A.; Edlin, Brian R. // Journal of Drug Issues;Winter99, Vol. 29 Issue 1, p1 

    The article reports on the injection drug users (IDUs) and related diseases among drug injectors. The IDUs are considered to be at major risk for infection with human immunodeficiency virus (HIV) and other related diseases. These diseases include hepatitis B virus and hepatitis C virus. The...

  • Co-morbidities among injecting drug users with HIV in India - challenges in clinical management. Sarkar, Kamalesh; Chakrabarti, Sekhar // Indian Journal of Medical Research;May2008, Vol. 127 Issue 5, p428 

    The article examines the co-morbidities among injecting drug users (IDU) with HIV in India. Several studies are discussed which noted high prevalence of HIV coupled with hepatitis B virus (HBV) and hepatitis C virus (HCV) in IDU. The different factors needed to be considered in treatment of...

  • Risk of Infection From Needle Reuse at a Phlebotomy Center. Porco, Travis C.; Aragon, Tomás J.; Fernyak, Susan E.; Cody, Sara H.; Vugia, Duc J.; Katz, Michell H.; Bangsherg, David R. // American Journal of Public Health;Apr2001, Vol. 91 Issue 4, p636 

    Conclusions. The infection risk was very low; few, if any, transmissions are likely to have occurred. (Am J Public Health. 2001;91:636-638)

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics